Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Sarcoma × Trabectedin × 30 days × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Sarcoma 1 Chondrosarcoma, Mesenchymal 1

Interventions

Specimen Handling 9 Magnetic Resonance Spectroscopy 7 Biopsy 7 Doxorubicin 6 Gemcitabine 5 X-Rays 4 Phantoms, Imaging 4 tazemetostat 3 pembrolizumab 3 liposomal doxorubicin 3 Ifosfamide 3 ulixertinib 2 palbociclib 2 ivosidenib 2 ensartinib 2 Temozolomide 2 Surveys and Questionnaires 2 Standard of Care 2 Radiotherapy 2 Radiation 2 Nuclear Medicine Department, Hospital 2 Nivolumab 2 LY3023414 2 Irinotecan 2 Fluorodeoxyglucose F18 2 Docetaxel 2 Cyclophosphamide 2 Carboplatin 2 Albumin-Bound Paclitaxel 2 trastuzumab deruxtecan 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04383119 2026-03-25

ISG-ARTICLE

Italian Sarcoma Group

Phase 2 Recruiting

Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡